The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy ...
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback